Therapeutic formulations for the treatment of cold and flu-like symptoms

Details for Australian Patent Application No. 2008280801 (hide)

Owner Kingsway Pharmaceuticals Inc.

Inventors Lomaga, Mark Andrew

Agent Griffith Hack

Pub. Number AU-A-2008280801

PCT Pub. Number WO2009/012590

Priority 60/935,012 23.07.07 US

Filing date 23 July 2008

Wipo publication date 29 January 2009

International Classifications

A61K 31/192 (2006.01)

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 31/167 (2006.01) - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61K 31/198 (2006.01)

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

18 March 2010 PCT application entered the National Phase

  PCT publication WO2009/012590 Priority application(s): WO2009/012590

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008280806-Methods for the diagnosis, risk assessment, and monitoring of autism spectrum disorders

2008280799-Immunogenic polypeptides and monoclonal antibodies